Facebook tracking pixel
S10.AI
ICD-10-CM · R78.81GeneralSystemic

Bacteremia

Understanding bacteremia, bloodstream infection, and blood infection diagnosis, treatment, and clinical documentation is crucial for healthcare professionals. This resource provides information on bacteremia symptoms, causes, ICD-10 codes, medical coding guidelines, and best practices for accurate clinical documentation and patient care. Learn about blood culture testing, antibiotic treatment options, and sepsis management related to bacteremia. Explore relevant information for physicians, nurses, and other medical professionals involved in the diagnosis and management of bacteremia and related bloodstream infections.

Also known as
Bloodstream InfectionBlood Infection
Definition

Presence of bacteria in the bloodstream.

Clinical signs

Fever, chills, rapid heart rate, low blood pressure, confusion.

Common settings

Hospital-acquired infections, intravenous lines, surgical procedures.

Related Codes

ICD-10 Code Families

Complete code families applicable to R78.81

A40-A41
Other bacterial diseases
R78.81
Bacteremia
A00-B99
Certain infectious and parasitic diseases
Code Comparison

When to use each related code

DescriptionWhen to use
Bacteria in the bloodstream.Use for positive blood cultures or strong clinical suspicion with systemic signs.
Systemic inflammatory response to infection.Use for suspected infection with 2+ SIRS criteria (fever, tachycardia, tachypnea, leukocytosis).
Infection originating from a localized site.Document the source of infection (e.g., pneumonia, UTI) and 'with bacteremia' if applicable.
Documentation

Best-practice checklist

  • Document positive blood culture results.
  • Specify organism identified and sensitivities.
  • Note source of bacteremia if known (e.g., UTI).
  • Document signs/symptoms (e.g., fever, chills).
  • Record treatment plan (e.g., antibiotics).
Coding & Audit Risks

Common pitfalls to avoid

Sepsis Miscoding

Confusing bacteremia with sepsis or severe sepsis can lead to inaccurate coding and DRG assignment.

Clinical Validation

Insufficient documentation to support bacteremia diagnosis may cause coding and billing errors.

Unspecified Organism

Lack of specificity regarding the causative organism impacts coding accuracy and reimbursement.

Mitigation

Best-practice tips

  • 01Timely blood cultures, appropriate antibiotics (ICD-10 A49.9, R78.8)
  • 02Aseptic technique for IV lines, catheters (CPT 77002, 76937)
  • 03Remove unnecessary catheters promptly (CDI, infection prevention)
  • 04Hand hygiene, chlorhexidine skin prep (quality measures, compliance)
  • 05Monitor patient, adjust treatment based on cultures (SNOMED CT 40847001)
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify positive blood culture: organism, source

  2. 2

    Review patient's signs/symptoms (fever, chills, hypotension)

  3. 3

    Assess risk factors: central lines, immunosuppression, recent surgery

  4. 4

    Consider alternative diagnoses: localized infection, drug reaction

  5. 5

    Document infection source and antibiotic treatment plan

Documentation Template

Ready-to-paste narrative

Patient presents with signs and symptoms suggestive of bacteremia, also known as a bloodstream infection or blood infection.  Clinical manifestations include fever, chills, rigors, tachycardia, hypotension, and altered mental status.  The patient's medical history includes [relevant comorbidities, e.g., diabetes, indwelling catheter, recent surgery].  Physical examination reveals [relevant findings, e.g., warm skin, flushed appearance,  murmur].  Preliminary differential diagnosis includes sepsis, septic shock, and other infectious processes.  Blood cultures have been drawn and sent for laboratory analysis to identify the causative organism and determine antibiotic susceptibility.  Empiric antibiotic therapy has been initiated with [antibiotic name and dosage] pending culture results.  The patient's condition is being closely monitored for signs of clinical deterioration.  Further diagnostic workup may include complete blood count (CBC) with differential, procalcitonin, lactate, and imaging studies as clinically indicated.  Treatment plan includes intravenous fluids, hemodynamic support, and adjustment of antibiotics based on culture results and clinical response.  Patient education provided regarding bacteremia symptoms, treatment, and potential complications.  Coding considerations include ICD-10-CM code for bacteremia (B95.6) and appropriate CPT codes for blood cultures and other diagnostic and therapeutic procedures performed.  Differential diagnosis considerations for billing and medical necessity documentation include sepsis, severe sepsis, and septic shock, to be documented appropriately if suspected or confirmed.
FAQs

Common questions and answers

What are the most effective empiric antibiotic treatment strategies for suspected gram-negative bacteremia in critically ill adults, considering current resistance patterns?+

Empiric antibiotic therapy for suspected gram-negative bacteremia in critically ill adults must cover a broad spectrum of potential pathogens, including resistant organisms like *Pseudomonas aeruginosa* and *Enterobacteriaceae* producing extended-spectrum beta-lactamases (ESBLs) or carbapenemases. Current guidelines, such as those from the Infectious Diseases Society of America (IDSA) and local antibiograms, recommend initial treatment with a combination of a beta-lactam with activity against *Pseudomonas* (e.g., piperacillin-tazobactam, cefepime, meropenem, imipenem-cilastatin) and an aminoglycoside (e.g., gentamicin, tobramycin, amikacin). For patients with risk factors for carbapenem-resistant *Enterobacteriaceae* (CRE), alternative options include ceftazidime-avibactam, meropenem-vaborbactam, or colistin. De-escalation of therapy based on culture results and clinical response is crucial to minimize the emergence of resistance. Consider implementing rapid diagnostic testing, such as PCR or MALDI-TOF, to facilitate prompt identification of the causative pathogen and guide targeted antibiotic therapy. Explore how antimicrobial stewardship programs can optimize antibiotic use in your ICU.

How do I differentiate between true bacteremia and contamination in blood cultures drawn from patients with suspected bloodstream infections?+

Differentiating true bacteremia from blood culture contamination is a common challenge. Clinicians should consider several factors. True bacteremia is more likely with multiple positive blood cultures, especially if they grow the same organism. The clinical presentation of the patient, including fever, chills, hypotension, and other signs of systemic infection, supports the diagnosis of bacteremia. Common skin contaminants include coagulase-negative staphylococci, *Corynebacterium* species, *Propionibacterium acnes*, and *Bacillus* species. However, these organisms can occasionally cause true infection, especially in immunocompromised patients or those with indwelling medical devices. The time to positivity in blood cultures can also be helpful; rapid growth of pathogens typically suggests true bacteremia. Repeating blood cultures after appropriate skin disinfection helps rule out contamination. Learn more about best practices for blood culture collection and interpretation to improve diagnostic accuracy.

What are the key recommendations for the duration of antibiotic therapy for uncomplicated gram-positive bacteremia, considering factors like source control and clinical response?+

The optimal duration of antibiotic therapy for uncomplicated gram-positive bacteremia depends on several factors, including the causative organism, source of infection, and clinical response. For uncomplicated *Staphylococcus aureus* bacteremia without an indwelling medical device, current guidelines generally recommend 14 days of intravenous antibiotics after the first negative blood culture and documented clinical improvement. For streptococcal bacteremia, shorter courses (7-10 days) may be sufficient if the source is controlled and the patient responds favorably. However, longer durations may be necessary for infections involving prosthetic valves or other implantable devices. Adequate source control, such as removal of infected catheters or drainage of abscesses, is paramount for successful treatment. Consider implementing clinical pathways for bacteremia management to standardize care and improve patient outcomes. Explore how telehealth can be used for monitoring patients receiving outpatient parenteral antibiotic therapy (OPAT).

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.